Your browser doesn't support javascript.
loading
The Impact of Bariatric Surgery on Breast Cancer Recurrence: Case Series and Review of Literature.
Zhang, Shijia; Ikramuddin, Sayeed; Beckwith, Heather C; Sheka, Adam C; Wirth, Keith M; Blaes, Anne H.
Afiliação
  • Zhang S; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, 420 Delaware Street, SE, MMC 480, Minneapolis, MN, 55455, USA.
  • Ikramuddin S; Department of Surgery, University of Minnesota, Minneapolis, MN, USA.
  • Beckwith HC; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, 420 Delaware Street, SE, MMC 480, Minneapolis, MN, 55455, USA.
  • Sheka AC; Department of Surgery, University of Minnesota, Minneapolis, MN, USA.
  • Wirth KM; Department of Surgery, University of Minnesota, Minneapolis, MN, USA.
  • Blaes AH; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, 420 Delaware Street, SE, MMC 480, Minneapolis, MN, 55455, USA. blaes004@umn.edu.
Obes Surg ; 30(2): 780-785, 2020 02.
Article em En | MEDLINE | ID: mdl-31359344
ABSTRACT

BACKGROUND:

Excess body weight has been associated with worsening breast cancer survival. While bariatric surgery has been associated with less incident of breast cancer, the role that bariatric surgery plays after breast cancer diagnosis in terms of both feasibility and in preventing breast cancer recurrence is unclear.

METHODS:

We report the outcomes of 13 individuals who underwent bariatric surgery after definitive breast cancer treatment at a single institution.

RESULTS:

Thirteen females diagnosed with breast cancer (69.2% stage I, 23.1% stage II) at a median age of 42 years received bariatric surgery between 2001 and 2017. The median age of bariatric surgery was 52 years. Of the 13 patients, 46.2% underwent laparoscopic Roux-en-Y gastric bypass and 38.5% laparoscopic sleeve gastrectomy. The median time from breast cancer treatment to bariatric surgery was 3 years. The procedures were well tolerated. One female developed an abdominal wall hematoma. The average weight loss after 1 year and 2 years was 28.1% and 28.2%, respectively. There was a single breast cancer recurrence with a median follow-up of 11.7 years after breast cancer diagnosis and 5.3 years after bariatric surgery.

CONCLUSIONS:

Bariatric surgery after breast cancer treatment is feasible and well tolerated. Prospective trials evaluating bariatric surgery in obese breast cancer survivors should be considered.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Obesidade Mórbida / Neoplasias da Mama / Cirurgia Bariátrica / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Obesidade Mórbida / Neoplasias da Mama / Cirurgia Bariátrica / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article